四川省宜宾市第一人民医院2010～2012年质子泵抑制剂应用分析  

Analysis of utilization of proton pump inhibitors drugs in the first people's hospital of Yibin from 2010 to 2012

作　　者：赵大贵[1] 唐文[1] 李友有[1] 

机构地区：[1]四川省宜宾市第一人民医院药剂科,四川宜宾644000

出　　处：《实用医院临床杂志》2013年第6期83-85,共3页Practical Journal of Clinical Medicine

摘　　要：目的了解我院质子泵抑制剂(proton pump Inhibitors,PPI)应用情况及趋势,为临床合理用药提供参考。方法回顾性分析2010～2012年我院PPI的销售金额、用药频度(DDD S)及限定日费用(DDC)等情况。结果 2010～2012年我院PPI的总销售金额及总DDD S呈逐年增长趋势;销售金额及DDD S排序居前三位的药品分别是泮托拉唑、奥美拉唑、雷贝拉唑;口服PPI的DDD S构成比较高,应用较多;注射用PPI的销售金额构成比及DDD S构成比逐年增加,应用增长较快。结论我院PPI使用数量及金额逐年增加,应用基本合理。Objective To investigate the status and trend of utilization of proton pump inhibitors （PPI）in our hospital in order to provide the clinical reference for rational drug use. Methods The consumption sum, DDD5, and defined daily cost （DDC） of the PPI drugs in our hospital during 2010-2012 were retrospectively analyzed. Results The total consumption sum and total DDDsof PPI drugs in our hospital were increased year by year. Pantoprazole, Omepraole, and Rabeprazole were the top three of consumption sum and DDD5. The DDD5, of oral PPI had relatively high proportion. Moreover, the consumption sum and DDD5. of injection PPI were increased year by year and grew rapidly. Conclusion The consumption sum and amount of the PPI agents in our hospital are increased year by year but the application is reasonable.

关 键 词：质子泵抑制剂 销售金额 限定日费用 用药频度 

分 类 号：R969.3[医药卫生—药理学] R975.2[医药卫生—药学]